CICON16: Beyond PD-1 and CTLA-4: The New Checkpoints September 26, 2016December 14, 2022 Arthur N. Brodsky, PhD
CICON16: Cancer Antigens and the Development of Personalized Immunotherapy Approaches September 26, 2016December 14, 2022 Arthur N. Brodsky, PhD
CICON16: Translating Science Into Survival September 24, 2016December 14, 2022 Arthur N. Brodsky, PhD
ASCO 2016 Update: Tapping into the Potential of Anti-Tumor T Cells June 17, 2016December 14, 2022 Arthur N. Brodsky, PhD
ASCO 2016 Update: Immunotherapy & Melanoma: The Path to Progress June 16, 2016December 14, 2022 Arthur N. Brodsky, PhD